Inflammation is a condition that predates humanity itself, as witnessed by the first signs of inflammatory processes observed on dinosaur bones. To limit the side effects of inflammation, the use of anti-inflammatory drugs is necessary. Finding an effective new drug with a low damage rate can cost up to US$1.8 billion and take around thirteen years. However, the advent of bioinformatics technologies has made this task easier and less costly.